Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis
- PMID: 3673513
- DOI: 10.1007/BF00688184
Histopathological criteria for progressive dementia disorders: clinical-pathological correlation and classification by multivariate data analysis
Abstract
Autopsied brains from 55 patients with dementia between 59-95 years of age (mean age 77.9 +/- 8.1 years) and 19 non-demented individuals between 46-91 years of age (mean age 74.3 +/- 10.5 years) were examined to establish histopathological criteria for normal ageing, primary degenerative [Alzheimer's disease (AD)/senile dementia of Alzheimer type (SDAT)] and vascular (multi-infarct) dementia (MID) disorders. Senile/neuritic plaques, neurofibrillary tangles, microscopic infarcts and perivascular serum protein deposits were quantified in the frontal lobe (Brodmann area 10) and in the hippocampus. The demented patients were classified according to the DSM-III criteria into AD/SDAT and MID. Operationally defined histopathological criteria for dementias, based on the degree/amount of the histopathological changes seen in aged non-demented patients, were postulated. The demented patients were clearly separable into three histopathological types, namely AD/SDAT, MID and AD-MID, the dementia type where both the degenerative and the vascular changes are coexistent in greater extent than are seen in the non-demented individuals. Using general clinical, gross neuroanatomical and histopathological data three separate dementia classes, namely AD/SDAT, MID and AD-MID, were visualized in two-dimensional space by multivariate data analysis. This analysis revealed that the pathology in the AD-MID patients was not merely a linear combination of the pathology in AD/SDAT and MID, indicating that AD-MID might represent a dementia type of its own. The clinical diagnosis for AD/SDAT and MID was certain in only half of the AD/SDAT and one third of the MID cases when evaluated histopathologically and by multivariate data analysis. AD/SDAT, MID and AD-MID were histopathologically diagnosed in 49%, 24% and 27%, respectively, of all the dementia cases studied. Opposite correlation between the number of tangles, plaques and the patient age in non-demented and AD/SDAT cases were observed, indicating that the pathogenesis of tangles and plaques in the two groups of patients might be different and that AD/SDAT might not be a form of an exaggerated ageing process.
Similar articles
-
Histopathological classification of dementias by multivariate data analysis.Prog Clin Biol Res. 1989;317:295-301. Prog Clin Biol Res. 1989. PMID: 2602421
-
Clinicopathological analysis of dementia disorders in the elderly.J Neurol Sci. 1990 Mar;95(3):239-58. doi: 10.1016/0022-510x(90)90072-u. J Neurol Sci. 1990. PMID: 2358819
-
[A comparative study on histopathological findings between Alzheimer's disease and senile dementia of Alzheimer type].Rinsho Byori. 1996 Mar;44(3):225-30. Rinsho Byori. 1996. PMID: 8857164 Review. Japanese.
-
Blood-brain barrier in Alzheimer dementia and in non-demented elderly. An immunocytochemical study.Acta Neuropathol. 1987;73(2):160-6. doi: 10.1007/BF00693782. Acta Neuropathol. 1987. PMID: 3300132
-
Laboratory diagnostic tests for Alzheimer's disease.Prog Clin Biol Res. 1989;317:679-87. Prog Clin Biol Res. 1989. PMID: 2690116 Review.
Cited by
-
Pathological Alterations of Tau in Alzheimer's Disease and 3xTg-AD Mouse Brains.Mol Neurobiol. 2019 Sep;56(9):6168-6183. doi: 10.1007/s12035-019-1507-4. Epub 2019 Feb 8. Mol Neurobiol. 2019. PMID: 30734228
-
Mechanisms of tau-induced neurodegeneration.Acta Neuropathol. 2009 Jul;118(1):53-69. doi: 10.1007/s00401-009-0486-3. Epub 2009 Jan 30. Acta Neuropathol. 2009. PMID: 19184068 Free PMC article. Review.
-
The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment.FASEB J. 2010 Nov;24(11):4420-32. doi: 10.1096/fj.10-158477. Epub 2010 Jul 22. FASEB J. 2010. PMID: 20651003 Free PMC article.
-
Alzheimer's Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound.Biomolecules. 2022 Oct 2;12(10):1409. doi: 10.3390/biom12101409. Biomolecules. 2022. PMID: 36291618 Free PMC article. Review.
-
Elevation of casein kinase 1ε associated with TDP-43 and tau pathologies in Alzheimer's disease.Brain Pathol. 2020 Mar;30(2):283-297. doi: 10.1111/bpa.12775. Epub 2019 Aug 22. Brain Pathol. 2020. PMID: 31376192 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Other Literature Sources
Medical